KaydedilenlerDerginizi ekleyin

Dergiler / Journal of Cellular Neuroscience and Oxidative Stress / 2019 / Cilt: 11 - Sayı: 2

Microglia and its role in neurodegenerative diseases

Kenan YILDIZHAN
Mustafa NAZIROĞLU
Sayfa
861–873
Yayın Tarihi
2019-06-23
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this review, the general characteristics and activation mechanism of microglial cells and their functional roles in Alzheimer's, Parkinson's, epilepsy and multiple sclerosis diseases were discussed in the current review.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Microglia are immune cells colonized in the central nervous system (CNS) during the development of the embryo.
📊
Temel Bulgular & Veri:They make up about 12% of the glial cell population in the brain.
💡
Sonuç & Katkı:In this review, the general characteristics and activation mechanism of microglial cells and their functional roles in Alzheimer's, Parkinson's, epilepsy and multiple sclerosis diseases were discussed in the current review.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Microglia · Alzheimer's Disease · Parkinson's Disease

Abstract

Microglia are immune cells colonized in the central nervous system (CNS) during the development of the embryo. They make up about 12% of the glial cell population in the brain. These cells play an important role in eliminating the damage that may occur in the CNS or in carrying out normal functions. Microglia cells, which are in morphologically inactive form, are characterized by small cell body, small amounts of cytoplasm and cellular extensions that are released towards the environment. They undergo a significant morphological change and switch to the active form in a pathophysiological condition in the CNS, and they have the ability to migrate to the damaged area by ameboid movement. In today's studies, microglial cells in the active form has been stated to show neuroprotective and neurotoxic effects in neuronal structures in addition to carrying out phagocytosis of metabolic residues in the medium. It has also been mentioned in recent studies that microglial cells located in the CNS have a highly sensitive activation mechanism against inflammation and pathological conditions. Understanding the microglial activation mechanism in neurodegenerative diseases is thought to may contribute to the diagnosis / treatment of neurological diseases as well as being a diagnostic marker for the etiology of the diseases. In this review, the general characteristics and activation mechanism of microglial cells and their functional roles in Alzheimer's, Parkinson's, epilepsy and multiple sclerosis diseases were discussed in the current review.

🔖

Bu Makaleye Atıf Yap

YILDIZHAN, K., NAZIROĞLU, M. (2019). Microglia and its role in neurodegenerative diseases. Journal of Cellular Neuroscience and Oxidative Stress, Cilt: 11 - Sayı: 2, 861–873. https://ajindex.com/articles/827261

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Airas L, Dickens AM, Elo P, Marjamaki P, Johansson J, Eskola O, Jones PA, Trigg W, Solin O, Haaparanta-Solin M, Anthony DC, and Rinne J. 2015. In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis. J Nucl Med. 56 (2): 305-310.
  2. Airas L, Nylund M, and Rissanen E. 2018. Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography. Front Neurol. 9: 181. Baecher-Allan C, Kaskow BJ, and Weiner HL. 2018. Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron. 97 (4): 742-768.
  3. Bast BO, Rickert U, Schneppenheim J, Cossais F, Wilms H, Arnold P, and Lucius R. 2018. Aldosterone exerts anti-inflammatory effects on LPS stimulated microglia. Heliyon. 4 (10): e00826. Bertolotto A, Agresti C, Castello A, Manzardo E, and Riccio A. 2018. 5D4 keratan sulfate epitope identifies a subset of ramified microglia in normal central nervous system parenchyma. J Neuroimmunol. 85 (1): 69-77.
  4. Boche D, Perry VH, and Nicoll JA. 2013. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol. 39 (1): 3-18.
  5. Calvello R, Cianciulli A, Nicolardi G, De Nuccio F, Giannotti L, Salvatore R, Porro C, Trotta T, Panaro MA, and Lofrumento DD. 2017. Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses. J Neuroimmune Pharmacol. 12 (2): 327-339.
  6. Chen P, Zhao W, Guo Y, Xu J, and Yin M. 2016. CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection. Biomed Res Int. 2016: 8090918. Choi SR, Howell OW, Carassiti D, Magliozzi R, Gveric D, Muraro PA, Nicholas R, Roncaroli F, and Reynolds R. 2012. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain. 135 (Pt 10): 2925-2937.
  7. Choudhury ME, Miyanishi K, Takeda H, Islam A, Matsuoka N, Kubo M, Matsumoto S, Kunieda T, Nomoto M, Yano H, and Tanaka J. 2020. Phagocytic elimination of synapses by microglia during sleep. Glia. 68 (1): 44-59.
  8. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, and Finsen B. 2008. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation. 5: 46. Colonna M, and Butovsky O. 2017. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol.